Key points are not available for this paper at this time.
In this review, we aim to provide a summary of the diverse immunophenotypic presentations of distinct entities associated with plasmacytoid dendritic cell (pDC) proliferation. These entities include the following: (1) blastic plasmacytoid dendritic cell neoplasm (BPDCN); (2) mature pDC proliferation (MPDCP), most commonly seen in chronic myelomonocytic leukemia (CMML); and (3) myeloid neoplasms with pDC differentiation, in which pDCs show a spectrum of maturation from early immature pDCs to mature forms, most commonly seen in acute myeloid leukemia (pDC-AML). Our aim is to provide a flow cytometry diagnostic approach to these distinct and sometimes challenging entities and to clarify the immunophenotypic spectrum of neoplastic pDCs in different disease presentations. In this review, we also cover the strategies in the evaluation of residual disease, as well as the challenges and pitfalls we face in the setting of immune and targeted therapy. The differential diagnosis will also be discussed, as blasts in some AML cases can have a pDC-like immunophenotype, mimicking pDCs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Siba El Hussein
University of Vermont
Wei Wang
Qingdao University
Cancers
The University of Texas MD Anderson Cancer Center
University of Vermont
Building similarity graph...
Analyzing shared references across papers
Loading...
Hussein et al. (Sat,) studied this question.
synapsesocial.com/papers/68e669beb6db6435875f5f53 — DOI: https://doi.org/10.3390/cancers16112118